Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Sandoz Inc. v. Amgen Inc., No. 14-1693 (Fed. Cir. Dec. 5, 2014)

Affirmed
Infringement
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 14-1693
Decided
December 5, 2014
Judge
Taranto, J.
Document
Precedential Opinion
Length
15 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Sandoz Inc. sued Amgen Inc. and Hoffman -La Roche Inc. to obtain a declaratory judgment that two patents , owned by Hoffman -La Roche and exclusively licensed to Amgen, are invalid and unenforceable and will not be infringed if Sandoz uses, offers to sell or s ells, or imports a drug product “ biosimilar” to Amgen’s Enbrel®.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error